The Nordic life science industry is booming and medical developments have never been this rapid. Nonetheless, in small countries like the Nordics, educational resources may not always be easy for the life science community to access. Now, five Nordic life science organisations from Sweden, Finland and Norway have joined forces to improve learning across borders.
“Each of us are small countries, through this collaboration we can provide more high-quality learning opportunities for Life Science professionals and for a broader Nordic-Baltic target group, instead of reinventing the wheel,” says Hanna Rickberg, Head of Education at the Swedish Academy of Pharmaceutical Sciences.
As part of the Nordplus Horizontal programme, educational events, training workshops and practical courses directed towards the life science industry will be made available online. The life science professionals can participate via a live video stream or pre-recorded material, making learning accessible to those on-site or on remote locations and in other countries.
The five partners in the project are:
- Swedish Academy of Pharmaceutical Sciences (Läkemedelsakademin)
- LIF – the Research Based Pharmaceutical Industry in Sweden (Läkemedelsindustriföreningen)
- Pharmaceutical Information Centre in Finland (PIC)
- The Association of the Pharmaceutical Industry in Norway (LMI – Legemiddelsindustrin)
- Oslo Cancer Cluster Incubator
“Life science is a global business and cross-border collaboration is important, in particular for small countries in the Nordics,” says Bjørn Klem, general manager at Oslo Cancer Cluster Incubator.
The project has received support from Nordplus to facilitate the sharing of educational resources across national borders in the Nordics. This will act as an innovation boost to the Nordic life science environments.
“We are intrigued by the opportunity to explore how we can establish synergies across the Nordic markets when it comes to meeting educational needs within the Life Science sector. The underlying assumption is that the needs are similar. Networking for future collaboration may present as a secondary benefit,” says Dag Larsson, Senior Policy Manager, LIF – the Research Based Pharma Industry in Sweden.
Nordic cooperation will be paramount to make the most of medical advances and to make personalized medicine a reality.
“We see Nordic cooperation as an essential value to the medical development that is now taking place with both personalised medicine and building a life science industry across the Nordic countries,” says Marie Svendsen Aase, communications advisor Legemiddelindustrien (LMI).
The project will run until 30 April 2021 and the five partners will share their courses via their websites and social media channels.
“Nordplus collaboration provides us an excellent opportunity to expand our training services to the Nordic market and to share knowledge with the other partners,“ says Anja Isoaho, Training Manager at Pharmaceutical Information Centre (Finland).
Next upcoming activity in the Nordplus course plan 2020-2021:
The 4th Nordic RWE Conference 2020, 11 February 2020, 09:00-17:00, arranged by LMI in Kaare Norum Auditorium, Oslo Cancer Cluster Innovation Park, Ullernchausseen 64, 0379 Oslo. This event will be streamed.